Replies to post #448290 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

This issue is such small potatoes (from a financial perspective) compared to Flaskwork’s highly probable certification, if DCVax-l is also approved. If you really look at what Ex is indirectly saying, it fits into the likelihood that non-flaskworks commercial production of DCVax is not likely in the cards in the medium to long term. That’s probably a very good thing. In other words, Flaskworks is (likely) the future.

[exwannabe]

The services agreement clearly states that DCVax products have dedicated access to the required space for a minimum (undisclosed) number of patients. So yes, DCVax has 'rights' to the cleanrooms/lab space/etc.

Yes, NWBO is paying for the reserved space. That contract runs another 4 months.

Advent has been able to meet that clause out of Royal Free so it is not much.

Even when the contract is extended (I expect it to be), Advent will still be able to use the facility as they want as long as they meet the minimum.